Medigene AG: Section 27a Notification
Medigene AG / Section 27a Notification . Processed and transmitted by NASDAQ
OMX Corporate Solutions. The issuer is solely responsible for the content of
Name: Medigene AG
Address: Lochhamer Str. 11, 82152 Planegg/Martinsried
Security Code Number: A1X 3W0
On 05 August 2014, Aviva plc informed us in accordance with Section 27a,
para.1, sent.3 German Securities Trading Act (Wertpapierhandelsgesetz - WpHG),
that Aviva plc has exceeded a 10% holding threshold in Medigene AG.
Aviva plc confirmed the following:
1.The investment is not aimed to implement strategic objectives but is aimed
at generating a trading profit.
2.There are no plans to acquire further voting rights within the next twelve
months by means of a purchase or by any other means.
3.It is not our objective to nominate onto or remove directors from the
Board, but if we feel there are issues with board composition we would, in
our engagement with the company encourage it to address any concerns we
may have. We expect boards to be effective in safeguarding shareholder
interests and they should have the right skills and experience to take the
company's strategy forward. In particular we recognise the important (and
independent) role of the chairman and non-executive directors in providing
appropriate internal challenge to board discussions and decisions to
ensure that all directors act in the best interests of the company. We
also place particular importance on boards setting appropriate standards
and values for the company both in terms of corporate responsibility and
also on doing the right thing in the way companies make decisions.
4.There are no intentions to achieve a material change in the Company's
capital structure, in particular as regards the ration between own funds
and external funds and the dividend policy.
Within Aviva plcs total holding of 1,400,000 shares (10.07%) acquired on 22
July 2014, Aviva plc confirms that 989,823 shares are held as a beneficial
(own funds) interest (7.12%) and the remaining 410,177 shares are held as a
non-beneficial (external funds) interest (2.95%).
The Executive Board
Planegg-Martinsried, 06 August 2014
Contact Medigene AG
Public & Investor Relations
Julia Hofmann / Anja Clausnitzer
Tel.: +49 - (0)89 - 20 00 33 33 01
Notification as PDF
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf
of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for
the content, accuracy and originality of the information contained therein.
Source: Medigene AG via Globenewswire
--- End of Message ---
Lochhamer Strasse 11 Martinsried / München Germany
WKN: A1X3W0;ISIN: DE000A1X3W00;
Listed: Freiverkehr in Börse Stuttgart,
Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg,
Freiverkehr in Börse Berlin,
Freiverkehr in Börse Düsseldorf,
Freiverkehr in Bayerische Börse München,
Freiverkehr in Niedersächsische Börse zu Hannover,
Prime Standard in Frankfurter Wertpapierbörse,
Regulierter Markt in Frankfurter Wertpapierbörse;
Press spacebar to pause and continue. Press esc to stop.